Novo Nordisk A/S logo
Novo Nordisk A/S NVO
$ 38.53 -1.33%

Annual report 2025
added 02-28-2026

report update icon

Novo Nordisk A/S Gross Profit 2011-2026 | NVO

Gross profit is a key indicator of how efficiently a company produces or sells its products. This metric helps assess a business’s ability to generate revenue at the initial stage, before accounting for all other expenses. Regular analysis of gross profit allows companies to respond in a timely manner to changes in cost of goods, pricing strategy, and market conditions.

Calculation formula:
Gross Profit = Revenue – Cost of Goods Sold (COGS)

Revenue — all cash inflows from the sale of goods or services.
Cost of Goods Sold — direct costs related to the production or acquisition of goods:
  • Raw materials and supplies
  • Wages of production personnel
  • Depreciation of equipment
  • Transportation and warehousing costs (if directly related to production)
Importance for business:
  • Assessing core business profitability
    If gross profit is declining, it may indicate rising production costs or falling sales.
  • Financial planning
    Gross profit is the basis for calculating other key metrics, such as operating and net profit.
  • Benchmarking against competitors
    Gross profit analysis helps compare the efficiency of different companies within the same industry.
  • Insights into pricing effectiveness
    If gross profit is low, the company may be pricing too low or failing to control costs effectively.
Reasons for a decline in gross profit:
  • Increase in raw material and supply costs
  • Rising production expenses
  • Price reductions due to competition
  • Decrease in sales volume
  • Currency exchange rate fluctuations (for imports/exports)

Gross profit is an important metric, but it does not provide a complete picture of a company’s financial health, as it does not account for administrative and selling expenses, taxes, debt burden, or depreciation.

Annual Gross Profit Novo Nordisk A/S

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
250 B 246 B 196 B 149 B 117 B 106 B 102 B 94.2 B 94.1 B 94.6 B 91.7 B 74.2 B 69.4 B 64.6 B 53.8 B

All numbers in DKK currency

Indicator range from annual reports

Maximum Minimum Average
250 B 53.8 B 120 B

Gross Profit of other stocks in the Biotechnology industry

Issuer Gross Profit Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
180 M - 2.43 % $ 254 M germanyGermany
Acorda Therapeutics Acorda Therapeutics
ACOR
119 M - -24.86 % $ 820 K usaUSA
Acer Therapeutics Acer Therapeutics
ACER
1.27 M - 2.71 % $ 14 M usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.52 B - - $ 40.3 B usaUSA
ADMA Biologics ADMA Biologics
ADMA
293 M $ 15.36 -2.17 % $ 3.66 B usaUSA
Cellectis S.A. Cellectis S.A.
CLLS
37.7 M $ 3.53 -3.54 % $ 116 M franceFrance
AgeX Therapeutics AgeX Therapeutics
AGE
102 K - -10.17 % $ 12.2 K usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
12.1 - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
-428 K - -18.52 % $ 27.3 M britainBritain
Nymox Pharmaceutical Corporation Nymox Pharmaceutical Corporation
NYMX
1 K - -19.68 % $ 18.4 M canadaCanada
Aptorum Group Limited Aptorum Group Limited
APM
-104 K $ 0.79 -1.15 % $ 4.31 M chinaChina
China SXT Pharmaceuticals China SXT Pharmaceuticals
SXTC
367 K $ 2.01 -1.36 % $ 2.86 M chinaChina
Adverum Biotechnologies Adverum Biotechnologies
ADVM
2.32 M - - $ 86.2 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
-523 K - -11.43 % $ 502 K usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
774 M - - - russiaRussia
Anika Therapeutics Anika Therapeutics
ANIK
103 M $ 14.05 -1.44 % $ 206 M usaUSA
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
143 M $ 74.36 -1.64 % $ 1.44 B usaUSA
Aravive Aravive
ARAV
5.68 K - -13.39 % $ 1.45 M usaUSA
Athersys Athersys
ATHX
1.44 M - 3.77 % $ 22.4 M usaUSA
AVEO Pharmaceuticals AVEO Pharmaceuticals
AVEO
4.77 M - - $ 521 M usaUSA
BioCryst Pharmaceuticals BioCryst Pharmaceuticals
BCRX
44.7 M $ 8.49 -0.18 % $ 1.75 B usaUSA
BridgeBio Pharma BridgeBio Pharma
BBIO
38.1 M $ 65.66 -0.78 % $ 12.6 B usaUSA
Acasti Pharma Acasti Pharma
ACST
-32.3 K - 4.01 % $ 150 M canadaCanada
BioDelivery Sciences International BioDelivery Sciences International
BDSI
14 M - -4.8 % $ 255 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
4.67 B - 0.49 % $ 251 B cayman-islandsCayman-islands
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
500 - -9.72 % $ 5.89 M usaUSA
Berkeley Lights Berkeley Lights
BLI
53.8 M - -7.31 % $ 87 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
-10.6 M - - $ 867 M germanyGermany
Aeterna Zentaris Aeterna Zentaris
AEZS
4.73 M - 5.93 % $ 314 M canadaCanada
BioLineRx Ltd. BioLineRx Ltd.
BLRX
19.7 M $ 2.69 -0.74 % $ 908 M israelIsrael
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
1.34 B $ 61.3 1.21 % $ 11.8 B usaUSA